
Is this your show? Claim this page
PodCred
The people behind this show
People get invited back because someone remembered they were great.
PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.
Hosts
Guests
Who is on this show?
Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.
Add a creditEpisodes
231 episodesSpark 20: Alex Dang | Everyone Agrees? Think Again. How Venture Capitalists Decide
Invest in the wrong startup and you lose one times your money. Miss the next Google and you lose ten thousand times. Most boards are built to avoid the first mistake. Venture capitalists play by different rules. They...
EP 185: Ivy Nguyen | IQ, EQ and the Execution Quotient Investors Fund
The trait a Silicon Valley AI investor rewards most in a management team has a name almost nobody uses: XQ. IQ brings the idea and EQ reads the people across the table. The execution quotient shows in something as small...
EP 184: Ivy Nguyen | 10,000 AI Pitches and the One Test That Matters
In 2017 another investor told Ivy Nguyen that artificial intelligence was too small a niche to dedicate a fund to. More than ten thousand AI pitches later, every pitch deck says AI. Single funding rounds have grown...
EP 183: Marie Schroeder | Send the Rough Deck, Not the Perfect One
A seed investor at Novo Holdings would rather read your rough idea than your finished pitch deck. Most founders spend a year building the deck, forming the team and waiting until the story holds together. By the time it...
#182 - How to Lead When You Don't Know Where You Are Going: 4 Lessons from Ben Horowitz (Part 2 of 2)
What does it mean when the most respected adviser in Silicon Valley tells you that you are the best chief executive he works with, while your company is heading straight into a wall? Bill Campbell said exactly that to...
#181 - When Things Fall Apart: 3 Lessons from Ben Horowitz on Leading Through the Struggle (Part 1 of 2)
What do you do on the morning when there are no good moves left? In March 2001, Ben Horowitz took Loudcloud public in the middle of the dot-com collapse. The bankers cut the price from ten dollars a share to six in the...
EP 180: Eric Ries | Why Good Companies Go Bad After Success
What happens when the moment a company finally succeeds is the moment it becomes most likely to be destroyed? Most founders assume the market rewards the better product and protects what they built. The legal reality...
EP 179: Joško Bobanović | Why Venture Capital Fights Human Instinct
What happens when the instinct to help a struggling company is exactly what prevents the strongest companies from succeeding? Venture capital forces investors to make decisions that can feel deeply uncomfortable: stop...
#178 - The Elon Musk Method: 7 Rules for Building What the Market Thinks Is Impossible
How can a company have the right numbers and still reach the wrong strategic conclusion? In 2017, Volkswagen’s chief executive mocked Tesla as one of the “world champions of big announcements.” At the time, Volkswagen...
EP 177: Alberto Chalon | Liquidity Before the IPO Window Opens
Private companies are staying private longer, and that changes who gets liquidity, when, and why. Founders, employees, and early investors can wait a decade or more for an IPO or acquisition. Meanwhile, venture funds...
Alasdair Milton, KPMG | Why Precision Medicine Still Fails Patients (SPARK20 – 168)
Only one in three eligible lung cancer patients receives the targeted therapy they should get. That is not a failure of science. It is a failure of delivery. After more than two decades of precision oncology, biopharma...
#176 - Why Smart People Say Yes: 7 Lessons from Influence by Robert Cialdini
Some books explain how the world works. Influence explains why people move. Why someone takes the meeting. Why an investor leans in. Why a customer trusts. Why a team follows. Why a board stays stuck. Why a founder...
EP 175: Stefanie Schubert | Why Smart People Lose Negotiations Before They Start
Most leaders think negotiation begins when both sides sit down to talk numbers. By then, trust, incentives, timing, internal alignment, and first impressions have already shaped the outcome. That is why smart founders,...
EP 174: Wanwipa Siriwatwechakul | Funding the Next Industrial Era
Most people still treat climate solutions as a cost. Wanwipa Siriwatwechakul argues that this is exactly why so many leaders miss the real opportunity. The next industrial era will not be built by patching old systems,...
EP 173: Bret Kugelmass | The West Bet on the Wrong Energy Future
Power demand is rising faster than the systems meant to support it. AI, electrification, and industry all need stable energy, but the dominant story sold to the public was far simpler than reality. In this episode, Bret...
#172 - Fast Forward Thinking: Why Most Investments Fail — And How Elite VCs Think Differently
Most investors think they’re rational. Most founders think they’re disciplined. Most boards think they’re strategic. They’re usually wrong. In this episode, we unpack Fast Forward Thinking by Luis Pareras - a physician...
EP 171 - Björn Cochlovius: Why Brilliant Biotech Breaks at Manufacturing
Most biotech breakthroughs don’t fail in the lab. They fail when science meets manufacturing reality. And by the time this bottleneck appears, tens of millions are already sunk. This episode examines the most...
EP 170 - Jim Pulcrano: Why Most Venture Capital Fails And What Europe Still Gets Wrong
Nine out of ten startups fail, yet Europe keeps funding them the same way. Governments replace judgment with bureaucracy, capital replaces experience, and failure is misunderstood instead of learned from. This...
EP 169 - Why New Year’s Goals Fail by February - Even for Disciplined People
Most goals don’t fail because of laziness or lack of ambition. They fail quietly - buried under daily noise, competing priorities, and forgotten intentions. By March, even the most meaningful goals have slipped down the...
EP 168 - Why Breakthrough Medicines Don’t Reach Patients | Alasdair Milton, KPMG
A breakthrough medicine can exist. A patient can qualify. The treatment can still never reach them. What breaks between scientific discovery and patient care? And what does that mean for the people building, financing...
#167: Pattern Breakers — 7 Laws Behind Category-Defining Companies
Most founders obsess over ideas. Breakthrough companies obsess over inflections, conviction, and structure. This episode unpacks Pattern Breakers by Mike Maples Jr. - a book that quietly explains why most startups never...
SPARK20 – 156: Janos Pasztor | The Climate Diplomat Who Refuses to Give Up on Humanity
The world has grown quiet about climate change. Too quiet. We scroll past floods, fires, droughts… and move on with our day. As if the problem solved itself. As if we’ve earned the luxury to look away. Janos Pasztor...
EP 166 - Karl Nehammer: Why Europe Fails to Scale – And How the EIB Plans to Fix It
Europe leads the world in discovery - yet too often, its breakthroughs never become global companies. Billions in research funding turn into patents, not products. While others build empires from ideas, Europe risks...
EP 165 – Jason Foster: 153 Rejections Later — What Every Founder Must Learn About Resilience
Most founders dream of raising millions. Few survive the 153 “no’s” it takes to get there. Behind every biotech breakthrough lies exhaustion - late-night calls, failed rounds, and investors who walk away at the finish...
EP 164 - Kat Kozyrytska: AI in Pharma Is a Yesterday Problem – Why Ethical Frameworks Can’t Wait
Imagine waking up to find your company’s most valuable IP leaked - not by hackers, but by the very AI tools you trusted. This isn’t a distant scenario; it’s happening inside pharma and biotech right now. And the cost...
#163: The NVIDIA Way — 7 Scaling Lessons from Jensen Huang’s Playbook
Most founders obsess over products. Jensen Huang built a $3 trillion company by obsessing over inevitabilities. This episode unpacks The NVIDIA Way by Tae Kim - the definitive account of how NVIDIA went from near-death...
Marc Penkala | Why Being Wrong is the Secret to Venture Success (SPARK20 – 139)
How do you succeed in a business where being wrong is the norm? Marc Penkala has lived both sides of the table: as an entrepreneur who built, sold, and failed with companies - and now as a venture capitalist running his...
EP 162 - Alex Oppenheimer: The Secret Investors Use Before Writing the First Check
Here’s the harsh truth: If your business model can’t survive a spreadsheet, it won’t survive the market. Every year, ambitious founders pour months into product, pitch, and brand - yet the single biggest reason startups...
EP 161 - Enis Hulli: VC Secrets Exposed: Why Only US-Based Startups Dominate (and How to Beat the Odds)
Why do Europe’s brightest founders still feel forced to leave for Silicon Valley - no matter how much money or talent we pour into the region? Every year, ambitious startups across Europe and CEE struggle to scale - not...
EP 160 - Vadim Fedotov: Elevate Your Wellbeing: How Data-Driven Choices Create Peak Performance
Still trying to optimize your health with guesswork and generic advice? Most people settle for “one-size-fits-all” supplements and hope for the best-missing out on the breakthroughs that only real data and...
Angeli Möller | Building the Future of Health with Precision, Vision, and Heart (SPARK20 – 142)
How do you lead at the cutting edge of health, data, and AI - while staying deeply human? Angeli Möller has led global data science teams across pharma giants, co-founded one of Europe’s most ambitious AI alliances, and...
#159: No Rules Rules — 7 Culture Principles That Made Netflix Unstoppable
Most founders add layers to gain control. Reed Hastings built an empire by removing them. This episode unpacks No Rules Rules - the leadership playbook behind Netflix’s rise from a DVD mail service to a global...
EP 158 - Rafael Rosengarten: Why 90% of Cancer Drugs Fail — and the Radical AI Fix You’ve Never Heard Of
Most cancer drugs fail. Not because the science is wrong - because we’re solving the wrong problems. The cost? Over $2 billion per failure. And for the patient waiting on a miracle - there’s no second chance. Behind the...
EP 157 - Fabrizio Conicella: Why Europe Keeps Losing the Next Breakthroughs in Medicine
Europe has the science. The talent. The breakthroughs. But when an idea feels too uncertain, our systems shut it down before it has a chance to breathe. And with every safe bet… we quietly lose the next cure, the next...
EP 156 - Janos Pasztor: The Most Controversial Fix for Climate Change
What if the only way to save the planet... is to cool it? Not figuratively - literally. Because the heatwaves, floods, and fires you’ve seen so far? They’re just the beginning. 🌍 Emissions keep rising. Global...
#155: Ray Dalio’s Playbook — 7 Principles for Building Scalable, Resilient Companies
What if your business ran like a well-designed machine - one that could evolve, self-correct, and outperform your competition over decades? In this episode, I unpack Principles by Ray Dalio, the billionaire investor and...
Suzanne Heywood | From Shipwreck to Boardroom Leadership (SPARK20 - 133)
What does it take to turn extreme adversity into extraordinary leadership? Suzanne Heywood’s life reads like a novel - shipwrecked at seven, isolated at sea for a decade, forging her father’s signature to survive, and...
EP 154 - Kristina Levan: Why Life-Saving Therapies Aren’t Reaching Patients—And How to Fix It
ATMPs, gene therapies, and cancer breakthroughs are here - but outdated regulations, high costs, and logistical bottlenecks are blocking access. What needs to change for hospitals to deliver these cures to patients who...
EP 153 - Christopher Uhde: The Biotech IPO Boom is Over. Now What?
In 2021, biotech IPOs were soaring. Valuations hit record highs. Investors were throwing money at anything that moved. Then… the market crashed. Funding dried up. Growth stalled. Biotech founders and investors were left...
EP 152 Alex Dang: Conviction Beats Consensus | The Venture Mindset
Everyone agrees. The investment looks sensible. The committee approves. What might the room be missing? Alex Dang, co-author of The Venture Mindset with Stanford professor Ilya Strebulaev, explains why conviction can...
#151: Mastering Uncertainty – 7 Venture Secrets to Thriving in Chaos
What if your greatest asset in business was how you think under pressure? In this episode, I dive into The Venture Mindset by Alex Dang and Ilya Strebulaev, unpacking seven transformative lessons drawn from the world of...
Dan Bowyer: Rethinking Venture Capital with Superseed VC (SPARK 20 – 125)
What does it take to redefine venture capital while empowering founders to disrupt industries and drive meaningful change? Meet Dan Bowyer, a bold investor from Superseed VC reshaping the game with a no-nonsense...
EP 150: 2024 in Review: 9 Bold Steps Toward a Brighter 2025
What makes a year unforgettable? Is it the challenges conquered, the bold ideas pursued, or the connections that shaped us? As 2024 comes to a close, this special episode celebrates the lessons, breakthroughs, and...
EP 149: Marina Schmidt - How Do We Feed 10 Billion People Without Destroying the Planet?
Our global food systems are at a breaking point. Climate change, geopolitical tensions, and industrial farming are pushing us closer to food insecurity every day. Can we find a way to feed 10 billion people while...
Doerte Hirschberg: Investing in Climate Solutions and Transforming Industries (SPARK20 - 114)
What does it take to tackle the world's biggest challenge - climate change - while driving profit and innovation? Meet Doerte Hirschberg, a visionary investor reshaping industries with bold ideas and data-driven...
#148: Think Long-Term, Thrive Always: 7 Lessons From Investing Titans
What if your greatest advantage in business was how you think about the future? In this episode, I explore Richer, Wiser, Happier by William Green, unpacking seven actionable lessons inspired by legendary investors like...
SPARK 20 - 109: Philipp Baaske, CEO of Nanotemper
What does it take to lead a global biotech company tackling diseases like cancer and Alzheimer’s - and still treat every team member, from executives to production staff, as equals? In this 20-minute highlight episode,...
EP 147: DC Palter - Why Startups Face the 'Pit of Hell': The Truth About Securing Funding
Startups promise innovation, but why do so many fail to secure the funding they need? Investors demand results before committing, yet startups require resources to build. This paradox leaves founders stuck in what angel...
EP 146: Bio Europe - Will Europe’s Biotech Future Survive? Inside the Funding and Talent Exodus
Europe’s biotech sector is facing a crisis: despite its scientific achievements, it struggles with funding gaps and an exodus of top talent to the US. As biotech innovations drive global healthcare, Europe risks losing...
EP 145: Shlomo Noy - Why Healthcare Innovation Fails Without the Right Strategy
Healthcare investment is booming, but why do so few initiatives actually deliver lasting impact? While funding flows into biotech and life sciences, many leaders overlook the complex strategies needed to bridge research...
#144: 9 Life-Changing Principles from Charlie Munger: Smarter Investing and Decision-Making
What if you could rewire your thinking to solve life’s toughest problems? In this episode, we dive into Charlie Munger's timeless insights from Poor Charlie's Almanack, revealing 9 core principles for smarter investing,...
EP 143: Jordi Ferrer Rendé - Is Healthcare Destroying the Planet? The Shocking Truth About CO2 Emissions
Artificial intelligence is revolutionizing healthcare, but what if the real danger lies in the industry's carbon footprint? Despite healthcare’s purpose of saving lives, the industry contributes up to 10% of CO2...
EP 142: Angeli Moeller - Why AI Isn’t Transforming Healthcare Like It Should
Artificial intelligence is heralded as the future of healthcare, but why do so many innovations fail to make a tangible impact? Despite the hype, countless companies are missing critical opportunities to leverage AI...
EP 141: Alessandro Morra - How AI-Powered Robotics Will Transform Security—Are You Prepared for the Future?
Many companies today face increasing security challenges, yet few are leveraging the power of AI and robotics to protect their most critical assets. But what if these groundbreaking technologies could not only reduce...
#140: Customer Obsession Isn’t Enough—What Jeff Bezos Knows That Most Leaders Miss
What’s the secret to building a trillion-dollar company from scratch? In this episode, we uncover Jeff Bezos' game-changing strategies from Invent and Wander, revealing how Amazon became a global powerhouse. In the...
Posts
No posts yet. Posts Beginner's Mind shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Subscribe
Be on the front line of the show
Everything Beginner's Mind sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.
- The resources the host shares with subscribers
- Announcements before anyone else hears
- Behind the scenes from the team
- Events, invitations, and giveaways
- Only what the host sends, nothing else
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
















